These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
418 related items for PubMed ID: 21194734
1. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study. Tsoumpou I, Valasoulis G, Founta C, Kyrgiou M, Nasioutziki M, Daponte A, Koliopoulos G, Malamou-Mitsi V, Karakitsos P, Paraskevaidis E. Gynecol Oncol; 2011 Apr; 121(1):49-53. PubMed ID: 21194734 [Abstract] [Full Text] [Related]
2. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening]. Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF. Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350 [Abstract] [Full Text] [Related]
3. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program. Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F. Acta Cytol; 2012 Nov 25; 56(5):506-14. PubMed ID: 23075891 [Abstract] [Full Text] [Related]
4. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology. Carozzi F, Cecchini S, Confortini M, Becattini V, Cariaggi MP, Pontenani G, Sani C, Ciatto S. Cancer; 2006 Apr 25; 108(2):119-23. PubMed ID: 16411180 [Abstract] [Full Text] [Related]
5. The triage of low-grade cytological abnormalities by the immunocytological expression of cyclin-dependent kinase inhibitor p16INK4a versus Human Papillomavirus test: a real possibility to predict cervical intraepithelial neoplasia CIN2 or CIN2+. Stănculescu R, Brătilă E, Bauşic V, Vlădescu T. Rom J Morphol Embryol; 2013 Apr 25; 54(4):1061-5. PubMed ID: 24399002 [Abstract] [Full Text] [Related]
6. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening. Cuzick J, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Del Mistro A, Frayle H, Girlando S, Sani C, Confortini M, Zorzi M, Giorgi-Rossi P, Rizzolo R, Ronco G, New Technologies for Cervical Cancer Screening Working Group. Int J Cancer; 2020 Oct 01; 147(7):1864-1873. PubMed ID: 32170961 [Abstract] [Full Text] [Related]
7. The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Guo M, Hu L, Baliga M, He Z, Hughson MD. Am J Clin Pathol; 2004 Dec 01; 122(6):894-901. PubMed ID: 15539381 [Abstract] [Full Text] [Related]
8. Value of P16 expression in the triage of liquid-based cervical cytology with atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions. Ma YY, Cheng XD, Zhou CY, Qiu LQ, Chen XD, Lü WG, Xie X. Chin Med J (Engl); 2011 Aug 01; 124(16):2443-7. PubMed ID: 21933584 [Abstract] [Full Text] [Related]
9. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP, Prendiville WJ. Cochrane Database Syst Rev; 2013 Mar 28; 2013(3):CD008054. PubMed ID: 23543559 [Abstract] [Full Text] [Related]
10. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, De Marco L, Giorgi-Rossi P, Pontenani G, Rosso S, Sani C, Sintoni C, Segnan N, Zorzi M, Cuzick J, Rizzolo R, Ronco G, New Technologies for Cervival Cancer Screening (NTCC) Working Group. Lancet Oncol; 2008 Oct 28; 9(10):937-45. PubMed ID: 18783988 [Abstract] [Full Text] [Related]
11. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases. Byun SW, Lee A, Kim S, Choi YJ, Lee YS, Park JS. Int J Med Sci; 2013 Oct 28; 10(12):1602-7. PubMed ID: 24151431 [Abstract] [Full Text] [Related]
12. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study. Fujii T, Saito M, Hasegawa T, Iwata T, Kuramoto H, Kubushiro K, Ohmura M, Ochiai K, Arai H, Sakamoto M, Motoyama T, Aoki D. Int J Clin Oncol; 2015 Feb 28; 20(1):134-42. PubMed ID: 24744261 [Abstract] [Full Text] [Related]
13. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial. Wright TC, Behrens CM, Ranger-Moore J, Rehm S, Sharma A, Stoler MH, Ridder R. Gynecol Oncol; 2017 Jan 28; 144(1):51-56. PubMed ID: 28094038 [Abstract] [Full Text] [Related]
14. p16(INK4a) is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia. Samarawardana P, Dehn DL, Singh M, Franquemont D, Thompson C, Gaido L, Torkko KC, Homer P, Burke S, Titmus MA, Nayi V, Shroyer KR. Cancer Cytopathol; 2010 Jun 25; 118(3):146-56. PubMed ID: 20544710 [Abstract] [Full Text] [Related]
15. The role of p16(INK4a) immunostaining in the risk assessment of women with LSIL cytology: a prospective pragmatic study. Valasoulis G, Tsoumpou I, Founta C, Kyrgiou M, Dalkalitsis N, Nasioutziki M, Kassanos D, Paraskevaidis E, Karakitsos P. Eur J Gynaecol Oncol; 2011 Jun 25; 32(2):150-2. PubMed ID: 21614901 [Abstract] [Full Text] [Related]
16. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China. Pan QJ, Hu SY, Guo HQ, Zhang WH, Zhang X, Chen W, Cao J, Jiang Y, Zhao FH, Qiao YL. Gynecol Oncol; 2014 May 25; 133(2):172-9. PubMed ID: 24631450 [Abstract] [Full Text] [Related]
17. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China. Liao GD, Sellors JW, Sun HK, Zhang X, Bao YP, Jeronimo J, Chen W, Zhao FH, Song Y, Cao Z, Zhang SK, Xi MR, Qiao YL. Int J Cancer; 2014 Apr 01; 134(7):1715-24. PubMed ID: 24105727 [Abstract] [Full Text] [Related]
18. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old. Pirtea L, Secosan C, Margan M, Moleriu L, Balint O, Grigoras D, Sas I, Horhat F, Jianu A, Ilina R. Bosn J Basic Med Sci; 2019 Nov 08; 19(4):336-341. PubMed ID: 29924960 [Abstract] [Full Text] [Related]
19. Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion. Waldstrøm M, Christensen RK, Ørnskov D. Cancer Cytopathol; 2013 Mar 08; 121(3):136-45. PubMed ID: 22987560 [Abstract] [Full Text] [Related]
20. CINtec PLUS and cobas HPV testing for triaging Canadian women referred to colposcopy with a history of low-grade squamous intraepithelial lesion: Baseline findings. Ratnam S, Jang D, Gilbert L, Alaghehbandan R, Schell M, Needle R, Ecobichon-Morris A, Wang PP, Rahman M, Costescu D, Elit L, Zahariadis G, Chernesky M. Papillomavirus Res; 2020 Dec 08; 10():100206. PubMed ID: 32828968 [Abstract] [Full Text] [Related] Page: [Next] [New Search]